FAVRILLE INC has a total of 28 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are CEBIX INC, ONCLAVE THERAPEUTICS LTD and DASSEUX JEAN-LOUIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Mexico | 2 | |
#7 | Singapore | 2 | |
#8 | United States | 2 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Bioinformatics | |
#5 | Measuring microorganism processes | |
#6 | Microorganisms | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Gold Daniel P | 22 |
#2 | Shopes Robert J | 17 |
#3 | Gold Daniel P Shopes Robert J | 2 |
#4 | Robert J Shopes | 1 |
#5 | Daniel P Gold | 1 |
Publication | Filing date | Title |
---|---|---|
AU2005203503A1 | Method and composition for altering a T cell mediated pathology | |
CN1882609A | Altering a B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent | |
WO2005030931A2 | Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent | |
SG128482A1 | Method and composition for altering a b cell mediated pathology | |
US6911204B2 | Method and composition for altering a B cell mediated pathology | |
CN1468124A | Method and composition for altering a T cell mediated pathology | |
AU2001283304B2 | Method and composition for altering a T cell mediated pathology | |
AU8327201A | A molecular vector identification system |